Isn’t This Just Snacking? The Potential Adverse Effects of Night-Eating Symptoms on Treatment Adherence and Outcomes in Patients With Diabetes
Response to Morse et al.
- Katsunori Nonogaki, MD, PHD1,
- Kyoko Tateishi2 and
- Naohiko Nonogaki, MD, PHD2
- 1Center of Excellence, Division of Molecular Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan
- 2Nonogaki Diabetes Clinic, Ichinomiya, Aichi, Japan
- Address correspondence to Katsunori Nonogaki, MD, PhD, Associate Professor, Center of Excellence, Division of Molecular Metabolism and Diabetes, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. E-mail: knonogaki-tky{at}umin.ac.jp
As reported by Morse et al. (1), night-eating syndrome (NES) is likely to produce an adverse outcome in patients with type 2 diabetes. NES is defined as a circadian delay in daily food intake distinguished by evening hyperphagia (25% daily food intake consumed after the evening meal) and/or nighttime awakenings to eat at least three times per week (2). In addition to eating greater amounts of food in the evening hours, patients with NES often choose disproportionately large quantities of fat- …
